Gian Lifecare Q1 Results with Net Income Falls to ₹0.09 Crores

Gian Lifecare Q1 Results: Gian Lifecare's Q1 results for June 2024 show important changes in their financial performance. The Total Revenue for this quarter was ₹1.98 crores, which is lower than the ₹2.43 crores reported in June 2023, indicating a year-over-year (YoY) decline. This means that compared to the same time last year, the company earned less money. In terms of QoQ (quarter-on-quarter) performance, revenue increased slightly from ₹1.55 crores in March 2024 to ₹1.98 crores in June 2024, which is a positive sign, but still not enough to match last year's numbers.

Gian Lifecare’s he Selling, General, and Admin Expenses were ₹0.16 crores this quarter, down from ₹0.22 crores in June 2023, showing a YoY decrease. Similarly, Total Operating Expenses decreased from ₹2.05 crores last year to ₹1.88 crores this quarter, reflecting improved cost management. However, the Net Income was only ₹0.09 crores this quarter compared to ₹0.26 crores in June 2023, a decrease of YoY income. Even though Gian Lifecare saw improvement in some areas of QoQ, the overall YoY results show that the company still faces challenges compared to last year.

Here is a summary of Gian Life Care's Q1 results for the fiscal period ending June 2024:

(Rs. in Crores)

Source: Here 

For More Q1 Results check our Twitter Page

Visit our website for more Q1 results

Gian Lifecare Q1 Results

Gian Lifecare's financial results for the quarter ending on June 30, 2024, show important information about the company's performance. The total revenue, which includes money earned from operations and other income, was ₹215.25 million for this quarter, which is lower than ₹478.71 million from the previous year. This decline in revenue indicates challenges in the company's sales or market conditions.

Gian Lifecare also faced higher expenses this quarter, totaling ₹198.74 million, compared to ₹167.90 million last year. Major costs included materials consumed, employee salaries, finance costs, depreciation, and other operational expenses. Due to these increased expenses, the profit before tax was only ₹16.51 million this quarter, a significant drop from ₹310.80 million in the previous year.

Gian Lifecare After deducting tax expenses, the profit for the quarter was ₹10.62 million, a sharp decrease compared to ₹219.99 million the previous year. This resulted in earnings per share dropping to ₹0.10, down from ₹2.12. Overall, these results show that Gian Lifecare is facing financial difficulties, with lower revenues and profits compared to the previous year, indicating the need for the company to improve its operations and profitability.

Here’s the financial summary presented in a table format, comparing the unaudited results for the quarter ended June 30, 2024, with the audited results for the year ended March 31, 2024.

(Rs. in Crores, except the shares)

Gian Lifecare Financial Performance

Gian Lifecare is a company with a market cap of ₹21.6 crore, which means it is valued at that amount in the stock market. The current price of its stock is ₹20.9, and it has reached a high of ₹29.0 and a low of ₹18.5 in the past. The price-to-earnings (P/E) ratio is 5.23, indicating that the stock may be undervalued compared to its earnings. The book value is ₹19.0, showing the company's net asset value per share. Gian Lifecare does not offer dividends, as the yield is 0.00%. It has a return on capital employed (ROCE) of 29.2% and a return on equity (ROE) of 24.6%, reflecting strong profitability.

Here’s the information you provided in a simple table format:

Quarterly Results 

The table shows the financial performance of Gian Lifecare for the quarters ending in December 2023, March 2024, and June 2024. In December 2023, the company had sales of 3.79 crores and a net profit of 1.63 crores, with an operating profit margin (OPM) of 59.10%. By March 2024, sales increased to 4.60 crores, and the net profit rose to 2.20 crores, showing good growth, while the OPM improved to 67.61%. 

Here’s the table showing only the data for Dec 2023, Mar 2024, and Jun 2024:

(Rs. in Crores)

About Gian Lifecare 

Gian Lifecare is a well-known healthcare company in India that specializes in pathology services. We aim to provide high-quality medical testing with quick results for our patients. Our laboratories are spread across the country, making it easier for people to access our services. We have our own laboratory that is accredited by NABL, which means we meet strict quality standards. We also have ISO 9001:2015 certification, showing our commitment to quality management. Gian Lifecare offers a wide range of tests, with around 1,344 different types available.

These tests cover areas like biochemistry, hematology, and clinical pathology, helping doctors diagnose and treat various health conditions. We serve individual patients, hospitals, and corporate clients, providing reliable and convenient healthcare solutions. At Gian Lifecare, we believe in making healthcare accessible and efficient for everyone, ensuring that our customers receive the best possible care.